Gene-gene interaction between CETP and APOE polymorphisms confers higher risk for hypertriglyceridemia in oldest-old Chinese women

Experimental Gerontology

Volumn 55, Issue , 2014, Pages 129-133

  Sun, Liang ^a   Hu, Caiyou ^b   Zheng, Chenguang ^c   Huang, Zezhi ^d   Lv, Zeping ^b   Huang, Jin ^a   Liang, Siying ^a   Shi, Xiaohong ^a   Zhu, Xiaoquan ^a   Yuan, Huiping ^a   Yang, Ze ^a  

^a BEIJING HOSPITAL   (China)

^b Guangxi Zhuangzu Zizhiqu Jiangbin Yiyuan   (China)

^c Guangxi Matemal and Child Health Hospital   (China)

^d Yongfu Committee of the Chinese People's Political Consultative Conference   (China)

Author keywords

APOE; CETP; Gene gene interaction; Hypertriglyceridemia; Longevity

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL ESTER TRANSFER PROTEIN; TRIACYLGLYCEROL; CETP PROTEIN, HUMAN; LIPID;

AGED; AGING; ARTICLE; CHINESE; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; GENDER; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; HYPERTRIGLYCERIDEMIA; LONGEVITY; MAJOR CLINICAL STUDY; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; VERY ELDERLY; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CASE CONTROL STUDY; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; MIDDLE AGED; YOUNG ADULT;

ADULT; AGED, 80 AND OVER; APOLIPOPROTEINS E; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHOLESTEROL ESTER TRANSFER PROTEINS; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTRIGLYCERIDEMIA; LIPIDS; LONGEVITY; MIDDLE AGED; POLYMORPHISM, GENETIC; YOUNG ADULT;

EID: 84899792580     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2014.04.003     Document Type: Article

References (20)

1. Anon Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002, 106:3143-3421.
2. Barzilai N., Atzmon G., Schechter C., Schaefer E.J., Cupples A.L., Lipton R., Cheng S., Shuldiner A.R. Unique lipoprotein phenotype and genotype associated with exceptional longevity. JAMA 2003, 290:2030-2040.
3. Bennet A.M., Di Angelantonio E., Ye Z., Wensley F., Dahlin A., Ahlbom A., Keavney B., Collins R., Wiman B., de Faire U., Danesh J. Association of apolipoprotein E genotypes with lipid levels and coronary risk. JAMA 2007, 298:1300-1311.
4. Brunzell J.D. Clinical practice. Hypertriglyceridemia. N. Engl. J. Med. 2007, 357:1009-1017.
5. Dupre M.E., Liu G., Gu D. Predictors of longevity: evidence from the oldest old in China. Am. J. Public Health 2008, 98:1203-1208.
6. Evans D., Diemert P. Not just genomewide association studies: rare variants in genes not identified through genomewide association studies also contribute to hypertriglyceridemia. Circ. Cardiovasc. Genet. 2012, 5:5-6.
7. Gudnason V., Kakko S., Nicaud V., Savolainen M.J., Kesaniemi Y.A., Tahvanainen E., Humphries S. Cholesteryl ester transfer protein gene effect on CETP activity and plasma high-density lipoprotein in European populations. The EARS Group. Eur. J. Clin. Investig. 1999, 29:116-128.
8. Hahn L.W., Ritchie M.D., Moore J.H. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003, 19:376-382.
9. Lamarche B., Uffelman K.D., Carpentier A., Cohn J.S., Steiner G., Barrett P.H., Lewis G.F. Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J. Clin. Invest. 1999, 103:1191-1199.
10. Moore J.H., Gilbert J.C., Tsai C.T., Chiang F.T., Holden T., Barney N., White B.C. A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibility. J. Theor. Biol. 2006, 241:252-261.
11. Ndiaye N.C., Said S., Stathopoulou M.G., Siest G., Tsai M.Y., Visvikis-Siest S. Epistatic study reveals two genetic interactions in blood pressure regulation. BMC Med. Genet. 2013, 14:2.
12. Panza F., Solfrizzi V., Colacicco A.M., Basile A.M., D'Introno A., Capurso C., Sabba M., Capurso S., Capurso A. Apolipoprotein E (APOE) polymorphism influences serum APOE levels in Alzheimer's disease patients and centenarians. Neuroreport 2003, 14:605-608.
13. Purcell S., Cherny S.S., Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
14. Sanders A.E., Wang C., Katz M., Derby C.A., Barzilai N., Ozelius L., Lipton R.B. Association of a functional polymorphism in the cholesteryl ester transfer protein (CETP) gene with memory decline and incidence of dementia. JAMA 2010, 303:150-158.
15. Schatz I.J., Masaki K., Yano K., Chen R., Rodriguez B.L., Curb J.D. Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. Lancet 2001, 358:351-355.
16. Song Y., Stampfer M.J., Liu S. Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann. Intern. Med. 2004, 141:137-147.
17. Stamler J., Daviglus M.L., Garside D.B., Dyer A.R., Greenland P., Neaton J.D. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA 2000, 284:311-318.
18. Sun L., Yang Z., Jin F., Zhu X.Q., Qu Y.C., Shi X.H., Wang L. The Gly482Ser variant of the PPARGC1 gene is associated with Type 2 diabetes mellitus in northern Chinese, especially men. Diabet. Med. 2006, 23:1085-1092.
19. Tagalakis A.D., Dickson J.G., Owen J.S., Simons J.P. Correction of the neuropathogenic human apolipoprotein E4 (APOE4) gene to APOE3 in vitro using synthetic RNA/DNA oligonucleotides (chimeraplasts). J. Mol. Neurosci. 2005, 25:95-103.
20. Thompson A., Di Angelantonio E., Sarwar N., Erqou S., Saleheen D., Dullaart R.P., Keavney B., Ye Z., Danesh J. Association of cholesteryl ester transfer protein genotypes with CETP mass and activity, lipid levels, and coronary risk. JAMA 2008, 299:2777-2788.